Access to anti-retroviral drugs, male in France
France: Access to anti-retroviral drugs, male was 89.0% in 2022. ▲ Rising
Access to anti-retroviral drugs, male in France, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in France is 89.0%, measured in 2022. That is the highest value across all 23 years on record.
That represents a change of up 4.7% over ten years.
Over the whole period, access to anti-retroviral drugs, male in France peaked at 89.0% in 2015 and was at its lowest, 79.0%, in 2002.
That places France 17th out of 141 countries with data for 2022, putting it in the top quarter.
The long-run direction has been consistently rising across the 23 years of available data.
Access to anti-retroviral drugs, male in France, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 80.0% | — |
| 2001 | 80.0% | +0.0% |
| 2002 | 79.0% | -1.2% |
| 2003 | 79.0% | +0.0% |
| 2004 | 79.0% | +0.0% |
| 2005 | 79.0% | +0.0% |
| 2006 | 79.0% | +0.0% |
| 2007 | 80.0% | +1.3% |
| 2008 | 81.0% | +1.2% |
| 2009 | 82.0% | +1.2% |
| 2010 | 83.0% | +1.2% |
| 2011 | 84.0% | +1.2% |
| 2012 | 85.0% | +1.2% |
| 2013 | 86.0% | +1.2% |
| 2014 | 87.0% | +1.2% |
| 2015 | 89.0% | +2.3% |
| 2016 | 89.0% | +0.0% |
| 2017 | 89.0% | +0.0% |
| 2018 | 88.0% | -1.1% |
| 2019 | 89.0% | +1.1% |
| 2020 | 88.0% | -1.1% |
| 2021 | 89.0% | +1.1% |
| 2022 | 89.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 79.8% | 79.0% | 82.0% | 10 |
| 2010s | 86.9% | 83.0% | 89.0% | 10 |
| 2020s | 88.7% | 88.0% | 89.0% | 3 |
Countries ranked near France
More gender data for France
- Child population (UN estimates and projections) 10,528 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.9027 % change on previous year (2030)
- Population 58,516 (2030)
- Working-age population (UN estimates and projections) 58,516 (2030)
- Population (UN estimates and projections), annual growth rate 0.327 % change on previous year (2030)
- Age population, age 00, female, interpolated 310,512 (2025)
- Age population, age 00, male, interpolated 325,288 (2025)
- Age population, age 01, female, interpolated 312,212 (2025)
- Age population, age 01, male, interpolated 326,662 (2025)
- Age population, age 02, female, interpolated 325,263 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in France?
- Access to anti-retroviral drugs, male in France was 89.0% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in France?
- The highest recorded value was 89.0% in 2015.
- What is the lowest access to anti-retroviral drugs, male recorded in France?
- The lowest recorded value was 79.0% in 2002.
- How does France rank for access to anti-retroviral drugs, male?
- France ranks 17th out of 141 countries with data for 2022.
- Is access to anti-retroviral drugs, male rising or falling in France?
- Over the last ten years it is up 4.7%. The long-run trend across the full record is rising.
- Where does this France data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.